(Q73413351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Simultaneous delivery of an active protein and neutralizing antibody: creation of separated regions of biological activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

A B Fleming

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W M Saltzman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

Journal of Controlled Release

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

29-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

Transport and elimination of recombinant human NGF during long-term delivery to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

Efficacy of growth factors in the accelerated closure of interstices in explanted meshed human skin grafts.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

Bone morphogenetic proteins: from basic studies to clinical approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

A quantitative bioassay for nerve growth factor (NGF) activity employing a clonal pheochromocytoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

The role of transcription-dependent priming in nerve growth factor promoted neurite outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2800%2900318-7

7 January 2021

10.1016/S0168-3659(00)00318-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11166405%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference